Please ensure Javascript is enabled for purposes of website accessibility
Emergent BioSolutions Stock Quote

Emergent BioSolutions (NYSE: EBS)

$10.36
(1.8%)
$0.18
Price as of March 31, 2023, 10:00 a.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Emergent BioSolutions Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
EBS -74.77% -80.32% -27.72% -11%
S&P -9.29% +55.60% +9.23% +194%

Emergent BioSolutions Company Info

Emergent BioSolutions makes the only FDA-approved anthrax vaccine.

News & Analysis

The Fool has written over 100 articles on Emergent BioSolutions.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
416%
 
S&P 500 Returns
120%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 04/01/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.